Physician profile
Suneet Kumar
NPI 1073175816
$1,164.47
in general payments reported to CMS, 2019-2025
10 companies · $384 in 2025
The $384 reported for 2025 was more than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $780 · 2025: $384.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $862 · Education: $303.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $861.51 |
| Education | $302.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $309.60 | 2024-2025 | |
| Astrazeneca Pharmaceuticals Lp | $268.33 | 2024-2025 | |
| Seagen INC. | $182.98 | 2024-2025 | |
| E.R. Squibb & Sons, L.L.C. | $122.08 | 2024 | Opdivo |
| Sobi, INC | $118.99 | 2024 | |
| Intera Oncology, INC | $92.03 | 2025 | Intera |
| Incyte Corporation | $22.20 | 2025 | Zynyz, Jakafi |
| Jazz Pharmaceuticals INC. | $17.06 | 2025 | |
| Integra Lifesciences Corporation | $16.50 | 2024 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Gilead Sciences, INC. | $14.70 | 2025 | Trodelvy |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Suneet Kumar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.